These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30304142)

  • 1. Evaluation of plaque characteristics in coronary artery patients with impaired glucose tolerance through optical coherence tomography.
    Jing S; Gao X; Yu B; Qiao H
    Rev Assoc Med Bras (1992); 2018 May; 64(5):433-437. PubMed ID: 30304142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plaque Characteristics in Coronary Artery Disease Patients with Impaired Glucose Tolerance.
    Suzuki K; Takano H; Kubota Y; Inui K; Nakamura S; Tokita Y; Kato K; Asai K; Shimizu W
    PLoS One; 2016; 11(12):e0167645. PubMed ID: 27936195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary angiographic studies of impaired glucose regulation and coronary artery disease in Chinese nondiabetic subjects.
    Yan Q; Gu WQ; Hong J; Zhang YF; Su YX; Gui MH; Zhang Y; Chi ZN; Zhang YW; Li XY; Ning G
    Endocrine; 2009 Dec; 36(3):457-63. PubMed ID: 19856135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of vildagliptin on the daily glucose profile and coronary plaque stability in impaired glucose tolerance patients with coronary artery disease: VOGUE-A multicenter randomized controlled trial.
    Yamamoto H; Konishi A; Shinke T; Otake H; Kuroda M; Osue T; Sawada T; Takaya T; Kawai H; Hashimoto N; Ohara T; Hirota Y; Sakaguchi K; Omori T; Ogawa W; Hirata KI
    BMC Cardiovasc Disord; 2021 Feb; 21(1):92. PubMed ID: 33588758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical usefulness of the thickness of preperitoneal and subcutaneous fat layer in the abdomen estimated by ultrasonography for diagnosing abdominal obesity in each type of impaired glucose tolerance in man.
    Soyama A; Nishikawa T; Ishizuka T; Ito H; Saito J; Yagi K; Saito Y
    Endocr J; 2005 Apr; 52(2):229-36. PubMed ID: 15863953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral glucose tolerance test and HbA₁c for diagnosis of diabetes in patients undergoing coronary angiography: [corrected] the Silent Diabetes Study.
    Doerr R; Hoffmann U; Otter W; Heinemann L; Hunger-Battefeld W; Kulzer B; Klinge A; Lodwig V; Amann-Zalan I; Sturm D; Tschoepe D; Spitzer SG; Stumpf J; Lohmann T; Schnell O
    Diabetologia; 2011 Nov; 54(11):2923-30. PubMed ID: 21773683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Insulin sensitivity and beta function in the first-degree relatives of type 2 diabetic patients].
    Han XY; Ji LN; Zhou XH
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1777-80. PubMed ID: 15631772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.
    Nitta Y; Tahara N; Tahara A; Honda A; Kodama N; Mizoguchi M; Kaida H; Ishibashi M; Hayabuchi N; Ikeda H; Yamagishi S; Imaizumi T
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1172-82. PubMed ID: 24229770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of CD14
    Yamamoto H; Yoshida N; Shinke T; Otake H; Kuroda M; Sakaguchi K; Hirota Y; Toba T; Takahashi H; Terashita D; Uzu K; Tahara N; Shinkura Y; Kuroda K; Nagasawa Y; Nagano Y; Tsukiyama Y; Yanaka KI; Emoto T; Sasaki N; Yamashita T; Ogawa W; Hirata KI
    Atherosclerosis; 2018 Feb; 269():245-251. PubMed ID: 29407600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships of coronary culprit-plaque characteristics with duration of diabetes mellitus in acute myocardial infarction: an intravascular optical coherence tomography study.
    Sheng Z; Zhou P; Liu C; Li J; Chen R; Zhou J; Song L; Zhao H; Yan H
    Cardiovasc Diabetol; 2019 Oct; 18(1):136. PubMed ID: 31629406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired fasting glucose is associated with increased severity of subclinical coronary artery disease compared to patients with diabetes and normal fasting glucose: evaluation by coronary computed tomographic angiography.
    Gurudevan S; Garg P; Malik S; Khattar R; Saremi F; Hecht H; DeMaria A; Narula J
    BMJ Open; 2016 Aug; 6(8):e005148. PubMed ID: 27531720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of HbA1c and oral glucose tolerance test for diagnosis of diabetes in patients with coronary artery disease.
    Farhan S; Jarai R; Tentzeris I; Kautzky-Willer A; Samaha E; Smetana P; Jakl-Kotauschek G; Wojta J; Huber K
    Clin Res Cardiol; 2012 Aug; 101(8):625-30. PubMed ID: 22391987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy.
    Khaleeli AA; Johnson JN; Taylor WH
    Diabetes Metab Res Rev; 2007 Jan; 23(1):43-8. PubMed ID: 16703622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Features of coronary plaque in patients with metabolic syndrome and diabetes mellitus assessed by 3-vessel optical coherence tomography.
    Yonetsu T; Kato K; Uemura S; Kim BK; Jang Y; Kang SJ; Park SJ; Lee S; Kim SJ; Jia H; Vergallo R; Abtahian F; Tian J; Hu S; Yeh RW; Sakhuja R; McNulty I; Lee H; Zhang S; Yu B; Kakuta T; Jang IK
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):665-73. PubMed ID: 23922003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of stable HbA(1c) for supportive marker to diagnose diabetes mellitus in Japanese subjects.
    Tanaka Y; Atsumi Y; Matsuoka K; Mokubo A; Asahina T; Hosokawa K; Shimada S; Matsunaga H; Takagi M; Ogawa O; Onuma T; Kawamori R
    Diabetes Res Clin Pract; 2001 Jul; 53(1):41-5. PubMed ID: 11378212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does HbA1C predict isolated impaired fasting glycaemia in the oral glucose tolerance test in subjects with impaired fasting glycaemia?
    Likhari T; Aulakh TS; Singh BM; Gama R
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):418-20. PubMed ID: 18583629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in men with coronary artery disease assessed by angiography and disturbances of carbohydrate metabolism.
    Kowalska I; Straczkowski M; Szelachowska M; Kinalska I; Prokop J; Bachórzewska-Gajewska H; Stepien A
    Metabolism; 2002 Jun; 51(6):733-6. PubMed ID: 12037726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action.
    Faerch K; Vaag A; Holst JJ; Glümer C; Pedersen O; Borch-Johnsen K
    Diabetologia; 2008 May; 51(5):853-61. PubMed ID: 18317726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.